(BPT) – Diabetes Alert Day on March 25 is more than just a date on the calendar — it’s a wake-up call for millions of Americans who either live with diabetes or are at risk of developing it. It’s a ...
Embecta Corp., a global diabetes care company, recently announced it has received 510(k) clearance from the U.S. Food and Drug Administration for its disposable insulin delivery system. Indicated for ...
Companies will jointly develop niia™ signature, an all-in-one wearable insulin patch pump that provides integrated insulin delivery with real-time glucose sensing Collaboration aims to reduce daily ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Higher consumption of rye, oats and fruits increased the ...
An intestinal patch device containing insulin that can be swallowed in the form of a capsule, in development by researchers at University of California Santa Barbara, has demonstrated efficacy of ...
PARSIPPANY, N.J., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. ("embecta") (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, today announced it has ...
One of the diabetes market’s newest spinoffs is set to undergo a significant change. Embecta, which was spun out of Becton Dickinson in April of 2022, is instituting a restructuring plan that includes ...
Simplifying insulin resistance, a clinically significant condition that acts as a root cause for type 2 diabetes, obesity, ...
Through this strategic collaboration, PharmaSens and SiBionics aim to simplify diabetes management by combining their respective strengths in insulin-delivery innovation and CGM technology. The new ...
While 9 out of 10 people with diabetes are living with T2D, many of the automated insulin delivery solutions currently on the market were designed for people living with T1D. 300-unit insulin ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results